Winton Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Winton Group's RMD Position: Q4 2022 in Review
Winton Group sold out of ResMed (RMD) in Q4 2022, closing a stake of 2,719 shares — an estimated $594K sold.
Winton Group first reported a position in RMD in Q2 2014 and held it in 24 quarters. The position peaked at $45M in Q1 2015. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.
- Winton Group reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
- Winton Group sold 2,719 ResMed shares in Q4 2022, an estimated $594K.
- Winton Group first reported a position in ResMed in Q2 2014 and held it in 24 quarters.
- Winton Group's ResMed position peaked at $45M in Q1 2015.
- 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.
Based on Winton Group's 13F filing for Q4 2022, filed 14 Feb 2023.